Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9871622rdf:typepubmed:Citationlld:pubmed
pubmed-article:9871622lifeskim:mentionsumls-concept:C1414549lld:lifeskim
pubmed-article:9871622lifeskim:mentionsumls-concept:C0162826lld:lifeskim
pubmed-article:9871622lifeskim:mentionsumls-concept:C1709694lld:lifeskim
pubmed-article:9871622lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:9871622pubmed:issue1lld:pubmed
pubmed-article:9871622pubmed:dateCreated1999-1-26lld:pubmed
pubmed-article:9871622pubmed:abstractTextA series of hydroxamic acids related to the non-selective matrix metalloprotease inhibitor Batimastat is described, which inhibits the proteolytic cleavage of the low affinity IgE receptor from cell membrane preparations. Limited SAR studies suggest that the structural requirements for effective inhibition are distinct from those required for the inhibition of collagenase.lld:pubmed
pubmed-article:9871622pubmed:languageenglld:pubmed
pubmed-article:9871622pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:citationSubsetIMlld:pubmed
pubmed-article:9871622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9871622pubmed:statusMEDLINElld:pubmed
pubmed-article:9871622pubmed:monthJanlld:pubmed
pubmed-article:9871622pubmed:issn0960-894Xlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:MayerR JRJlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:BolognesiFFlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:BuckleD RDRlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:JacksonSSlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:SmithD GDGlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:BaileySSlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:FallerAAlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:MarshallL ALAlld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:Louis-Flamber...lld:pubmed
pubmed-article:9871622pubmed:authorpubmed-author:McCordMMlld:pubmed
pubmed-article:9871622pubmed:issnTypePrintlld:pubmed
pubmed-article:9871622pubmed:day6lld:pubmed
pubmed-article:9871622pubmed:volume8lld:pubmed
pubmed-article:9871622pubmed:ownerNLMlld:pubmed
pubmed-article:9871622pubmed:authorsCompleteYlld:pubmed
pubmed-article:9871622pubmed:pagination23-8lld:pubmed
pubmed-article:9871622pubmed:dateRevised2005-10-13lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:meshHeadingpubmed-meshheading:9871622-...lld:pubmed
pubmed-article:9871622pubmed:year1998lld:pubmed
pubmed-article:9871622pubmed:articleTitleHydroxamate-based inhibitors of low affinity IgE receptor (CD23) processing.lld:pubmed
pubmed-article:9871622pubmed:affiliationSmithKline Beecham Pharmaceuticals, Epsom, Surrey, UK.lld:pubmed
pubmed-article:9871622pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:9871622lld:chembl